A detailed history of Grimes & Company, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Grimes & Company, Inc. holds 100,742 shares of JNJ stock, worth $14.5 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
100,742
Previous 98,966 1.79%
Holding current value
$14.5 Million
Previous $14.5 Million 12.87%
% of portfolio
0.45%
Previous 0.44%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$145.48 - $167.38 $258,372 - $297,266
1,776 Added 1.79%
100,742 $16.3 Million
Q2 2024

Jul 22, 2024

BUY
$144.38 - $157.78 $150,299 - $164,248
1,041 Added 1.06%
98,966 $14.5 Million
Q1 2024

Apr 17, 2024

BUY
$155.22 - $162.74 $343,036 - $359,655
2,210 Added 2.31%
97,925 $15.5 Million
Q4 2023

Jan 24, 2024

BUY
$145.6 - $158.88 $370,406 - $404,190
2,544 Added 2.73%
95,715 $15 Million
Q3 2023

Oct 19, 2023

BUY
$155.75 - $174.48 $53,889 - $60,370
346 Added 0.37%
93,171 $14.5 Million
Q2 2023

Jul 19, 2023

SELL
$154.35 - $166.11 $291,104 - $313,283
-1,886 Reduced 1.99%
92,825 $15.4 Million
Q1 2023

Apr 20, 2023

BUY
$151.05 - $180.26 $1.82 Million - $2.17 Million
12,027 Added 14.55%
94,711 $14.7 Million
Q4 2022

Jan 25, 2023

BUY
$160.2 - $179.79 $794,592 - $891,758
4,960 Added 6.38%
82,684 $0
Q3 2022

Oct 28, 2022

BUY
$161.33 - $179.52 $335,727 - $373,581
2,081 Added 2.75%
77,724 $12.7 Million
Q2 2022

Jul 22, 2022

BUY
$168.19 - $186.01 $351,012 - $388,202
2,087 Added 2.84%
75,643 $13.4 Million
Q1 2022

May 06, 2022

SELL
$158.14 - $179.59 $675,574 - $767,208
-4,272 Reduced 5.49%
73,556 $13 Million
Q4 2021

Feb 01, 2022

BUY
$155.93 - $173.01 $1.23 Million - $1.36 Million
7,859 Added 11.23%
77,828 $13.3 Million
Q3 2021

Nov 08, 2021

BUY
$161.5 - $179.47 $156,655 - $174,085
970 Added 1.41%
69,969 $11.3 Million
Q2 2021

Aug 04, 2021

BUY
$159.48 - $171.07 $213,862 - $229,404
1,341 Added 1.98%
68,999 $11.4 Million
Q1 2021

May 12, 2021

SELL
$153.07 - $170.48 $162,866 - $181,390
-1,064 Reduced 1.55%
67,658 $11.1 Million
Q4 2020

Feb 02, 2021

BUY
$137.11 - $157.38 $311,102 - $357,095
2,269 Added 3.41%
68,722 $10.8 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $215,764 - $236,436
1,537 Added 2.37%
66,453 $9.89 Million
Q2 2020

Jul 31, 2020

BUY
$128.81 - $155.51 $29,497 - $35,611
229 Added 0.35%
64,916 $9.13 Million
Q1 2020

May 05, 2020

BUY
$111.14 - $153.99 $175,934 - $243,766
1,583 Added 2.51%
64,687 $8.48 Million
Q4 2019

Feb 05, 2020

BUY
$127.5 - $146.44 $36,592 - $42,028
287 Added 0.46%
63,104 $9.21 Million
Q3 2019

Nov 05, 2019

BUY
$126.95 - $142.14 $127,076 - $142,282
1,001 Added 1.62%
62,817 $8.13 Million
Q2 2019

Jul 30, 2019

BUY
$131.15 - $144.24 $518,173 - $569,892
3,951 Added 6.83%
61,816 $8.61 Million
Q1 2019

May 02, 2019

BUY
$125.72 - $139.79 $137,160 - $152,510
1,091 Added 1.92%
57,865 $8.09 Million
Q4 2018

Feb 01, 2019

SELL
$122.84 - $147.84 $129,227 - $155,527
-1,052 Reduced 1.82%
56,774 $7.33 Million
Q3 2018

Nov 09, 2018

BUY
$121.58 - $142.88 $51,428 - $60,438
423 Added 0.74%
57,826 $7.99 Million
Q2 2018

Aug 10, 2018

BUY
$119.4 - $131.76 $1.33 Million - $1.47 Million
11,147 Added 24.1%
57,403 $6.97 Million
Q1 2018

May 07, 2018

BUY
$125.1 - $148.14 $504,278 - $597,152
4,031 Added 9.55%
46,256 $5.93 Million
Q4 2017

Feb 05, 2018

BUY
$131.22 - $143.62 $1.04 Million - $1.14 Million
7,944 Added 23.17%
42,225 $5.9 Million
Q3 2017

Nov 03, 2017

BUY
$129.47 - $135.38 $4.44 Million - $4.64 Million
34,281
34,281 $4.46 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $377B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Grimes & Company, Inc. Portfolio

Follow Grimes & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.